Company news
Microbix Biosystems Inc. news in 2007
Microbix Biosystems Inc.'s news releases, calls and decks from 2007, newest first.
Microbix Announces Year-End Results, Continuing Progress in Major Product Development
December 21, 2007
Microbix Signs Letters of Intent to License its Flu Vaccine Yield Enhancement Technology
December 14, 2007
Microbix Biosystems' CEO visits China to formalize the licensing agreement for the Company's SST technology and to discuss other business opportunities
November 13, 2007
Microbix Biosystems Completes $6.825 Million Private Placement
November 13, 2007
Microbix Biosystems granted U.S. patent for its influenza vaccine yield enhancement technology
October 22, 2007
ALS Therapy Development Institute Signs Manufacturing Agreement with Microbix
October 16, 2007
Microbix Hires Dr. Andre Uddin of BioStrategy Management
September 28, 2007
Microbix Announces Third Quarter Results
August 14, 2007
Microbix mobilizes SWATT team to help companies worldwide expand flu vaccine production
August 13, 2007
Microbix licenses its animal reproduction technology in China
June 27, 2007
Canadian company Microbix showcases vaccine yield enhancement discovery at world's largest conference on influenza
June 18, 2007
Market Regulation Services - Trade Resumption - Microbix Biosystems Inc. - MBX
June 12, 2007
Microbix identifies specific proteins that allow X and Y sperm cells to be separated; files for provisional patent
June 12, 2007
Market Regulation Services - Trading Halt - Microbix Biosystems Inc. - MBX
June 12, 2007
Canadian company Microbix' discovery could save many lives in flu pandemic; its technology to be granted U.S. patent
May 30, 2007
Microbix Announces Second Quarter Results and Provides Update on Product Development
May 15, 2007
Microbix Biosystems Completes Non-Brokered Private Placement Financing For Gross Proceeds of $1.05 Million
April 20, 2007
Microbix Provides Update on Urokinase Project Financing
March 28, 2007
Microbix granted patent on its Vaccine Technology
March 21, 2007
Microbix arranges $500,000 in additional financing for its potential blockbuster biological products
February 20, 2007
Microbix' first quarter results reflect continued substantial investments in its proprietary products
February 14, 2007
Microbix Announces Changes To Board of Directors
February 13, 2007
Microbix Realigns Executive Management Team To Support Revenue Growth and Accelerate Commercialization
January 10, 2007